Ambu Awarded National Single-Use Endoscopy Contract with Premier Inc.

August 28, 2020:  Today Ambu Inc., announced today that it has been awarded a single-use endoscopy contract in the category of Surgical Disposable Scopes with Premier Inc., one of the largest performance improvement alliances of hospitals and healthcare systems in the U.S. In addition, Ambu was the only supplier of single-use endoscopes designated to participate in Premier’s SURPASS and ASCEND purchasing programs.

The three-year agreement creates a single-use endoscopy category specifically for the Premier membership and was signed this week, effective November 1, 2020. The partnership with Premier – whose members represent 4,100 hospital and health systems in the U.S. and 200,000 other providers – will further accelerate Ambu’s rapidly expanding share of the single-use endoscope market by giving those accounts pre-negotiated pricing and terms for Ambu’s full suite of endoscopy products.

Premier’s SURPASSTM program represents $8.4 billion in annual supply chain purchasing, with more than 30,000 acute care beds across 24 states and two U.S. territories. The ASCEND group purchasing program, meanwhile, is one of the nation’s largest committed purchasing programs with more than 120,000 acute care beds and a combined purchasing volume of more than $18 billion.

Boosting Ambu’s market share

Ninety-six percent of the top 500 bronchoscopy accounts in the U.S. are already using Ambu’s sterile, single-use bronchoscopes in the OR and ICU. Over the past twelve months, Ambu has increased its market share in these accounts and across all US hospitals, as the market continues to transition to single-use bronchoscopy.
This partnership with Premier will further boost Ambu’s market share by giving more accounts access to its full suite of single-use endoscopy products.

“The agreement allows Ambu to tap into a vast market of hospitals, health systems and healthcare providers across the U.S. with our single-use endoscopes,” said Juan Jose Gonzalez, CEO of Ambu A/S. “It strengthens our position in the U.S. and demonstrates the value of our portfolio in improving workflows and increasing patient safety. Premier is an exceptional company that we have known for years and we look forward to continue building our relationship with a company that is transforming the healthcare industry.”

Premier is highly regarded for its work driving efficiencies in hospitals and healthcare systems. Over the years, it has developed an alliance of more than 4,100 U.S. hospitals and health systems and over 200,000 other providers and organizations.

Ambu launched the world’s first single-use flexible bronchoscope, the Ambu® aScopeTM in 2009. In 2019, over 600,000 Ambu single-use endoscopes were used in more than 6,000 hospitals making Ambu the world’s largest supplier of single-use endoscopes. In 2020, Ambu expects to sell over 1 million single-use endoscopes.

Ambu received 510(k) clearance from the U.S. Food and Drug Administration in July 2020 for its single-use aScopeTM Duodeno, and the FDA cleared Ambu’s aScopeTM 4 Cysto in April 2020. By 2022, Ambu plans to introduce another 12 new devices across all major areas of endoscopy, including GI, the largest endoscopy market globally.

SourceAmbu

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”